Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer vaccines: a clinical reality or fairy tale?
Curigliano G, Spitaleri G, Pietri E, Rescigno M, de Braud F, Cardillo A, Munzone E, Rocca A, Bonizzi G, Brichard V, Orlando L, Goldhirsch A. Curigliano G, et al. Ann Oncol. 2006 May;17(5):750-62. doi: 10.1093/annonc/mdj083. Epub 2005 Nov 17. Ann Oncol. 2006. PMID: 16293674 Free article. Review.
Cancer-testis antigen expression in triple-negative breast cancer.
Curigliano G, Viale G, Ghioni M, Jungbluth AA, Bagnardi V, Spagnoli GC, Neville AM, Nolè F, Rotmensz N, Goldhirsch A. Curigliano G, et al. Ann Oncol. 2011 Jan;22(1):98-103. doi: 10.1093/annonc/mdq325. Epub 2010 Jul 7. Ann Oncol. 2011. PMID: 20610479 Free article.
Targeting the subtypes of breast cancer: rethinking investigational drugs.
Curigliano G, Locatelli M, Fumagalli L, Brollo J, Munzone E, Nolé F, Criscitiello C, Goldhirsch A. Curigliano G, et al. Expert Opin Investig Drugs. 2012 Feb;21(2):191-204. doi: 10.1517/13543784.2012.651456. Epub 2012 Jan 10. Expert Opin Investig Drugs. 2012. PMID: 22229343 Review.
Immunotherapeutics for breast cancer.
Criscitiello C, Curigliano G. Criscitiello C, et al. Among authors: curigliano g. Curr Opin Oncol. 2013 Nov;25(6):602-8. doi: 10.1097/CCO.0000000000000020. Curr Opin Oncol. 2013. PMID: 24076578 Review.
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study.
Dieci MV, Criscitiello C, Goubar A, Viale G, Conte P, Guarneri V, Ficarra G, Mathieu MC, Delaloge S, Curigliano G, Andre F. Dieci MV, et al. Among authors: curigliano g. Ann Oncol. 2014 Mar;25(3):611-618. doi: 10.1093/annonc/mdt556. Epub 2014 Jan 8. Ann Oncol. 2014. PMID: 24401929 Free PMC article.
758 results